Update shared on31 Jul 2025
With no material changes in the discount rate or future P/E, the consensus analyst price target for Healthcare Services Group remains steady at $17.00.
What's in the News
- The company is prioritizing capital allocation towards organic growth, acquisitions, and opportunistic share repurchases, with an active evaluation of acquisition opportunities and $14.6 million in YTD buybacks; no acquisitions completed this quarter.
- From April to July, 566,997 shares (0.78%) were repurchased for $7.6 million; since the buyback program began, 2,666,997 shares (3.63%) have been bought back for $30.73 million.
- 2025 guidance for mid-single digit growth has been reiterated.
- The company was recently added to multiple Russell growth and small cap indexes, including the Russell 2000, 2500, and 3000 Growth Indexes, as well as several related benchmarks.
Valuation Changes
Summary of Valuation Changes for Healthcare Services Group
- The Consensus Analyst Price Target remained effectively unchanged, at $17.00.
- The Discount Rate for Healthcare Services Group remained effectively unchanged, at 6.53%.
- The Future P/E for Healthcare Services Group remained effectively unchanged, at 12.02x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.